Lazard, INC
Market Movers (8-K)
NYSE
LAZ
Lazard, INCLazard, Inc. announced its second quarter and first half 2026 financial results, highlighting strong net inflows in Asset Management and a leading position in Financial Advisory league tables.
Worse than expected
NYSE
LAZ
Lazard, INCLazard, Inc. announced the appointment of Kathy Elsesser to its Board of Directors, effective July 7, 2026, succeeding Andrew M. Alper who is retiring.
NYSE
LAZ
Lazard, INCLazard shareholders approved an amendment to declassify the Board of Directors over a three-year period.
NYSE
LAZ
Lazard, INCLazard, Inc. has entered into a definitive agreement to acquire Campbell Lutyens Holdings Limited to expand its private capital advisory capabilities.
Capital raise
NYSE
LAZ
Lazard, INCLazard, Inc. announced its definitive agreement to acquire Campbell Lutyens Holdings Limited, creating a leading global private capital advisory platform.
Delay expected
NYSE
LAZ
Lazard, INCLazard, Inc. announced the appointment of Tracy Farr as its new Chief Financial Officer, effective February 1, 2026, succeeding Mary Ann Betsch who will transition to a Senior Advisor role.
Quarterly Earnings (10-Q)
NYSE
LAZ
Lazard, INCLazard, Inc. announced its second quarter 2026 financial results, showing a notable increase in asset management fees driven by higher Assets Under Management, while investment banking and advisory fees experienced a decline.
Worse than expected
NYSE
LAZ
Lazard, INCLazard, Inc. announced its first quarter 2026 financial results, showcasing a significant increase in asset management fees and a notable gain from a business divestiture, despite a slight dip in financial advisory revenue.
Worse than expected
NYSE
LAZ
Lazard, INCLazard, Inc. reported a 12% increase in adjusted net revenue for Q3 2025, driven by growth in both Financial Advisory and Asset Management, despite a decline in GAAP net income due to a prior-year asset sale.
Better than expected
Capital raise
NYSE
LAZ
Lazard, INCLazard, Inc. announced a significant increase in net income for the second quarter and first half of 2025, primarily fueled by robust performance in its Financial Advisory segment.
Better than expected
NYSE
LAZ
Lazard, INCLazard's Q1 2025 net income rose despite a decline in investment banking revenue, driven by cost-saving initiatives and a lower effective tax rate.
Worse than expected
NYSE
LAZ
Lazard, INCLazard Inc. saw a significant increase in net revenue and operating income in Q3 2024, primarily driven by a rebound in investment banking activity.
Better than expected
Annual Reports (10-K)
NYSE
LAZ
Lazard, INCLazard, Inc. reported a 2% increase in net revenue for 2025, driven by growth in both Financial Advisory and Asset Management, despite a decline in net income.
Worse than expected
NYSE
LAZ
Lazard, INCLazard's 2024 annual report reveals a significant rebound in financial performance, fueled by a surge in Financial Advisory revenue and strategic investments in key growth areas.
Better than expected
NYSE
LAZ
Lazard, INCGlobal financial advisory and asset management firm Lazard reported a net loss in 2023, impacted by a downturn in M&A activity and significant cost-saving measures, but anticipates a strengthening M&A environment in 2024.
Worse than expected
Insider Trading (Form 4)
NYSE
LAZ
Lazard, INCKathy Elsesser, a Director of Lazard, Inc., received 3,982 shares of common stock on July 23, 2026.
NYSE
LAZ
Lazard, INCAnn-Kristin Achleitner, a Director at Lazard, Inc., reported the grant of Deferred Stock Units (DSUs) valued at $0, with conversion to common stock contingent upon her departure from the board.
NYSE
LAZ
Lazard, INCAndrew M. Alper, a Director at Lazard, Inc., has reported the acquisition of Deferred Stock Units (DSUs) as part of his non-executive director compensation.
NYSE
LAZ
Lazard, INCLazard, Inc. director Peter Harrison has reported the acquisition of Deferred Stock Units (DSUs) under the company's incentive plan.
NYSE
LAZ
Lazard, INCLazard Director Michelle Jarrard reported a transaction involving Deferred Stock Units (DSUs) under the company's incentive plan.
NYSE
LAZ
Lazard, INCLazard, Inc. director Iris Knobloch has reported the grant of Deferred Stock Units (DSUs) under the company's incentive plan.
Proxy Statements (Def-14A)
NYSE
LAZ
Lazard, INCLazard's 2026 Proxy Statement details upcoming shareholder votes on director elections, executive compensation, board declassification, and incentive plan amendments, alongside a review of 2025 performance.
NYSE
LAZ
Lazard, INCLazard is challenging Institutional Shareholder Services' (ISS) recommendation against its say-on-pay proposal, arguing that flawed peer group selection and equity award valuation methods led to an inaccurate assessment of executive compensation alignment with performance.
Worse than expected
NYSE
LAZ
Lazard, INCLazard Inc. has filed a definitive proxy statement with the Securities and Exchange Commission.
NYSE
LAZ
Lazard, INCLazard Inc. has released its proxy statement for the 2025 Annual Meeting of Shareholders, outlining key voting matters including the election of directors, an advisory vote on executive compensation, and the ratification of Deloitte & Touche LLP as the independent auditor.
Better than expected
NYSE
LAZ
Lazard, INCDEFA14A: Lazard Inc. Updates Proxy Statement Regarding Voting Requirements for Annual Shareholder Meeting
Lazard Inc. has issued a supplement to its proxy statement clarifying the voting requirements for proposals at the upcoming annual shareholder meeting on May 9, 2024.
NYSE
LAZ
Lazard, INCLazard Inc. has filed a definitive proxy statement with the Securities and Exchange Commission (SEC) pertaining to Section 14(a) of the Securities Exchange Act of 1934.
Schedule 13G - Passive Investments
NYSE
LAZ
Lazard, INCT. Rowe Price Associates, Inc. has filed a Schedule 13G, reporting beneficial ownership of 9,601,861 shares of Lazard Inc. common stock, representing 8.6% of the class.
NYSE
LAZ
Lazard, INCAriel Investments, LLC has filed a Schedule 13G reporting a 5.2% beneficial ownership stake in Lazard Inc. common stock.
NYSE
LAZ
Lazard, INCThe Vanguard Group filed an amended Schedule 13G, reporting zero beneficial ownership in Lazard Inc. following an internal realignment.
NYSE
LAZ
Lazard, INCFMR LLC and Abigail P. Johnson filed an amended Schedule 13G, disclosing a continued 10.1% beneficial ownership in Lazard Inc.'s common stock.
NYSE
LAZ
Lazard, INCT. Rowe Price Associates, Inc. has disclosed a 6.9% beneficial ownership stake in Lazard Inc., holding over 7.7 million shares.
NYSE
LAZ
Lazard, INCAriel Investments, LLC has filed an amended Schedule 13G, reporting a 4.7% beneficial ownership stake in Lazard Inc as of September 30, 2025.